NewsRx

Search our medical news database

Almost Family, Inc.

Almost Family Announces Pricing of 2,250,000 Common Shares

Published in Law and Health Weekly, May 3rd, 2008

Almost Family, Inc. (the "Company") (NASDAQ:AFAM) announced the pricing of 2,250,000 common shares at a public offering price of $17.75 per share. In connection with the public offering, the underwriter has been granted an option to purchase up to 337,500 additional common shares to cover over-allotments, if any. The offering is expected to close on April 16, 2008.

The net proceeds from the public offering, after underwriting discounts and estimated offering expenses, to the Company will be approximately $37,340,950. The Company intends to use the net proceeds from the public offering to repay indebtedness and for other general corporate purposes, including to fund...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook